18F-KSS3

N/A

Report date: 2025/11/21 17:15:28

NME

Base Information

Drug Name18F-KSS3

Drug Alias Name18F-KSS318-F-KSS3

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionPositron-emission tomography enhancers

TargetsGlucose-dependent insulinotropic receptor

Therapy Area/IndicationsDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesWake Forest University School Of Medicine

China Registration ClassN/A

Develop Information

Active CompaniesWake Forest University School Of Medicine

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 2

Inactive IndicationsN/A

Other Information

ATC CodeN/A